Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 3
2006 1
2007 3
2008 2
2009 5
2010 2
2011 3
2013 2
2014 6
2015 6
2016 4
2017 4
2018 4
2019 11
2020 13
2021 12
2022 13
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kwei ma (61 results)?
A systematic review of asymptomatic infections with COVID-19.
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, Ma K. Gao Z, et al. Among authors: ma k. J Microbiol Immunol Infect. 2021 Feb;54(1):12-16. doi: 10.1016/j.jmii.2020.05.001. Epub 2020 May 15. J Microbiol Immunol Infect. 2021. PMID: 32425996 Free PMC article.
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Zheng J, Wang T, Yang Y, Huang J, Feng J, Zhuang W, Chen J, Zhao J, Zhong W, Zhao Y, Zhang Y, Song Y, Hu Y, Yu Z, Gong Y, Chen Y, Ye F, Zhang S, Cao L, Fan Y, Wu G, Guo Y, Zhou C, Ma K, Fang J, Feng W, Liu Y, Zheng Z, Li G, Wang H, Cang S, Wu N, Song W, Liu X, Zhao S, Ding L, Selvaggi G, Wang Y, Xiao S, Wang Q, Shen Z, Zhou J, Zhou J, Zhang L. Zheng J, et al. Among authors: ma k. Cancer Commun (Lond). 2024 Apr;44(4):455-468. doi: 10.1002/cac2.12524. Epub 2024 Feb 29. Cancer Commun (Lond). 2024. PMID: 38421881
Omicron XE emerges as SARS-CoV-2 keeps evolving.
Ma K, Chen J. Ma K, et al. Innovation (Camb). 2022 May 10;3(3):100248. doi: 10.1016/j.xinn.2022.100248. Epub 2022 Apr 18. Innovation (Camb). 2022. PMID: 35464633 Free PMC article. No abstract available.
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial.
Sun C, Liu Y, Zhang P, Wang X, Xu Y, Lin X, Ma X, Guo Y, Qiu S, Shao G, Yang Z, Ma K. Sun C, et al. Among authors: ma k. J Cancer Res Clin Oncol. 2023 Feb;149(2):819-831. doi: 10.1007/s00432-021-03896-w. Epub 2022 Feb 22. J Cancer Res Clin Oncol. 2023. PMID: 35192053 Clinical Trial.
Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial.
Sun C, Wang X, Xu Y, Shao G, Chen X, Liu Y, Zhang P, Lin X, Ma X, Qiu S, He H, Yang Z, Ma K. Sun C, et al. Among authors: ma k. EClinicalMedicine. 2024 Jan 19;68:102422. doi: 10.1016/j.eclinm.2024.102422. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38304743 Free PMC article.
93 results